This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Konduri Srinivasa Krishna Murthy: Innovator in Pharmaceutical Chemistry
Introduction
Konduri Srinivasa Krishna Murthy, based in Hyderabad, Telangana, India, is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions through his innovative approach to drug formulation, particularly in the development of Sugammadex sodium. His work reflects a commitment to improving pharmaceutical processes and ensuring higher purity in medicinal compounds.
Latest Patents
Konduri has been awarded a patent for his invention titled "Process for the preparation of Sugammadex sodium and its novel polymorphic form." This patent outlines an improved method for the synthesis of Sugammadex sodium, achieving over 98.5% purity while minimizing impurities. The process effectively reduces the levels of monohydroxy Sugammadex sodium to less than 1.0% and any other known or unknown impurities to less than 0.15%, as determined by High-Performance Liquid Chromatography (HPLC). This advancement has significant implications for the pharmaceutical industry, enhancing the quality and efficacy of anesthetic drugs.
Career Highlights
Konduri currently works at Natco Pharma Limited, a leading pharmaceutical company where he utilizes his expertise to drive innovation in drug development. His experience and knowledge in pharmaceutical sciences have been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Konduri has collaborated with colleagues such as Vanga Prabhakar and Baddula Saidulu, both of whom share a commitment to advancing pharmaceutical technologies. Their teamwork has fostered an environment of creativity and innovation, leading to breakthroughs in drug formulation and production processes.
Conclusion
Konduri Srinivasa Krishna Murthy exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly through his patent for Sugammadex sodium, showcase his dedication to developing processes that enhance drug purity and effectiveness. As a vital member of Natco Pharma Limited, Konduri continues to influence the field of pharmaceuticals positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
